Clinical Trial

Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression

Name: Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression — clinical trial record (NCT05749289)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

This is an open-label whole-body PET/CT study for investigating the value of Al18F-octreotide PET/CT in patients with SSTR positive tumors

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2023-02-19; most recent amendment 2026-03-31.

Trial Details

NCT Number	NCT05749289
Lead Sponsor	Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions	SSTR Positive Tumors
Enrollment	400 participants
Start Date	2022-12-20
Primary Completion	2028-12-20 (estimated)
Study Completion	2029-12-20 (estimated)
Updated on ClinicalTrials.gov	2026-04-06